Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...

CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...